Matches in Wikidata for { <http://www.wikidata.org/entity/Q64675281> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q64675281 description "clinical trial" @default.
- Q64675281 description "ensayu clínicu" @default.
- Q64675281 description "klinisch onderzoek" @default.
- Q64675281 description "клінічне випробування" @default.
- Q64675281 name "Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma" @default.
- Q64675281 type Item @default.
- Q64675281 label "Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma" @default.
- Q64675281 prefLabel "Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma" @default.
- Q64675281 P1050 Q64675281-43962543-2AF7-4CFD-A9E1-4DEA8AD6C774 @default.
- Q64675281 P1132 Q64675281-A1B727D6-9C07-44ED-9924-4A1F17C2F270 @default.
- Q64675281 P1476 Q64675281-8CFE55DF-98DF-458E-B2E5-46C929B96E58 @default.
- Q64675281 P17 Q64675281-24374F85-BB20-46F0-876F-854B6DC07552 @default.
- Q64675281 P17 Q64675281-3854B9D0-F568-44E9-9157-9BDEA735841B @default.
- Q64675281 P17 Q64675281-4D81983C-7E71-4FE6-82B1-403EEEF68534 @default.
- Q64675281 P17 Q64675281-67E76FE0-23BA-410E-A8A6-A937D8068190 @default.
- Q64675281 P17 Q64675281-708238AF-F0BD-4C8F-8B2C-4242B2F82051 @default.
- Q64675281 P17 Q64675281-B2AFCB22-F4DB-49A1-B788-D666A9113929 @default.
- Q64675281 P17 Q64675281-D3586E7E-1E46-426A-BE58-57981DE007F3 @default.
- Q64675281 P17 Q64675281-DCFF3072-75BA-4570-9CD0-2422D09AC8C5 @default.
- Q64675281 P2899 Q64675281-6B756228-3DB4-4F07-AAE3-B583E5EFEBD5 @default.
- Q64675281 P3098 Q64675281-DCBACA25-CE0E-42AE-BE07-E2DCE7D826F3 @default.
- Q64675281 P31 Q64675281-364383E6-1D1F-4C6E-98B8-F4CCFCAC3C38 @default.
- Q64675281 P4135 Q64675281-07BB2EC8-FAA7-4357-985A-1C8E90C3658F @default.
- Q64675281 P4844 Q64675281-4646A0FD-C0DD-4FAE-9753-CD95621A2430 @default.
- Q64675281 P4844 Q64675281-7E568F1E-FFB1-4F5E-A6DE-F824907C997A @default.
- Q64675281 P580 Q64675281-8906BF84-B4C2-4119-8A11-7B6B4702404F @default.
- Q64675281 P582 Q64675281-5D73A6B8-981F-4576-9E12-E0BDFAD42320 @default.
- Q64675281 P6099 Q64675281-C200660F-2286-4A05-A33A-3D697050145C @default.
- Q64675281 P8363 Q64675281-39C07F0E-68FC-45D0-82E5-2B571716DBBA @default.
- Q64675281 P1050 Q180614 @default.
- Q64675281 P1132 "+488" @default.
- Q64675281 P1476 "A Phase II, Multicentre, Open, Randomised, Dose Ranging Study to Investigate the Efficacy of Combination Therapy Containing Dacarbazine (DTIC) Plus Low Dose Interferon Alpha (aIFN) Plus Thymosin a1 Versus Both DTIC Plus Thymosin a1 and DTIC Plus aIFN in Patients With Advanced -Stage Metastatic Malignant Melanoma" @default.
- Q64675281 P17 Q142 @default.
- Q64675281 P17 Q183 @default.
- Q64675281 P17 Q28 @default.
- Q64675281 P17 Q29 @default.
- Q64675281 P17 Q36 @default.
- Q64675281 P17 Q38 @default.
- Q64675281 P17 Q39 @default.
- Q64675281 P17 Q45 @default.
- Q64675281 P2899 "+18" @default.
- Q64675281 P3098 "NCT00911443" @default.
- Q64675281 P31 Q30612 @default.
- Q64675281 P4135 "+75" @default.
- Q64675281 P4844 Q20817234 @default.
- Q64675281 P4844 Q20817235 @default.
- Q64675281 P580 "2002-07-01T00:00:00Z" @default.
- Q64675281 P582 "2007-09-01T00:00:00Z" @default.
- Q64675281 P6099 Q42824440 @default.
- Q64675281 P8363 Q78089383 @default.